Evaluation of urinary vanin-1 for the early prediction of cisplatin-induced acute kidney injury during neoadjuvant chemotherapy for esophageal cancer
Cancer Chemotherapy and Pharmacology · 2025
DOI: 10.1007/s00280-024-04737-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2025. Verfasst von Tomonobu Uchino und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. uch…. Hauptthemen laut MEDLINE: Cisplatin, Acute Kidney Injury, Esophageal Neoplasms, Neoadjuvant Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: The Research Foundation for Pharmaceutical Sciences.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. uchinot@u-shizuoka-ken.ac.jp.
- Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. uchinot@u-shizuoka-ken.ac.jp.
- Laboratory of Clinical Pharmacokinetics, the Medical Frontier Center, Shizuoka General Hospital, 4-27-1 Kita Ando, Aoi-ku, Shizuoka, 420-8527, Japan. uchinot@u-shizuoka-ken.ac.jp.
- Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.
- Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.
- Laboratory of Clinical Pharmacokinetics, the Medical Frontier Center, Shizuoka General Hospital, 4-27-1 Kita Ando, Aoi-ku, Shizuoka, 420-8527, Japan.
ORCID-Profile: Tomonobu Uchino
Förderung
- The Research Foundation for Pharmaceutical Sciences
Zitieren
APA
Uchino, T., Iwano, Y., Miyazaki, Y., Nakajo, M., Osawa, M., Nagai, E., Taki, Y., Sato, S., Watanabe, M., Takagi, M., & Kagawa, Y. (2025). Evaluation of urinary vanin-1 for the early prediction of cisplatin-induced acute kidney injury during neoadjuvant chemotherapy for esophageal cancer. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04737-6
Vancouver
Uchino T, Iwano Y, Miyazaki Y, Nakajo M, Osawa M, Nagai E, et al. Evaluation of urinary vanin-1 for the early prediction of cisplatin-induced acute kidney injury during neoadjuvant chemotherapy for esophageal cancer. Cancer Chemotherapy and Pharmacology. 2025. doi:10.1007/s00280-024-04737-6
BibTeX
@article{Uchino2025,
author = {Uchino, Tomonobu and Iwano, Yuna and Miyazaki, Yasunori and Nakajo, Michiaki and Osawa, Misa and Nagai, Erina and Taki, Yusuke and Sato, Shinsuke and Watanabe, Masaya and Takagi, Masakazu and Kagawa, Yoshiyuki},
title = {Evaluation of urinary vanin-1 for the early prediction of cisplatin-induced acute kidney injury during neoadjuvant chemotherapy for esophageal cancer},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2025},
doi = {10.1007/s00280-024-04737-6}
}
EUVIMED